Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
MeiraGTx Holdings plc
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Biological Products, (No Diagnostic Substances)
Prev close 12.75 · gapped above the open, then crossed back over prior close. High/low 12.95 at 7:00 am ET, 12.52 at 10:45 am ET.
MeiraGTx Holdings plc has 4 disclosed suppliers and 4 disclosed customers. Each one is named in an SEC filing, either MeiraGTx Holdings plc’s own annual report or the counterparty’s, and carries the sentence that discloses it.
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“MeiraGTx UK II Limited and Johnson & Johnson Innovative Medicine also entered into a Supply Agreement on the Closing Date pursuant to which MeiraGTx UK II Limited agreed to manufacture and supply the RPGR Product for Johnson & Johnson Innovative Medicine (the "Supply Agreement").”
FILING10-K0001104659-26-036494cik 0001735438
“On November 7, 2025 (the "Effective Date"), our affiliates MeiraGTx Ocular UK Limited ("MeiraGTx Ocular"), MeiraGTx Limited and MeiraGTx UK II Limited, entered into a strategic collaboration and license agreement with Eli Lilly and Company ("Lilly") (the "Lilly Collaboration Agreement") for the research, development and commercialization of genetic medicines in and related to the area of ophthalmology.”
FILING10-K0001104659-26-036494cik 0001735438
“Certain of our issued patents and pending patent applications are exclusively licensed to us from UCLB, Brandeis University ("Brandeis") and the National Institute of Dental and Craniofacial Research ("NIDCR").”
FILING10-K0001104659-26-036494cik 0001735438
“In May 2013, BRI-Alzan Inc., or BRI-Alzan, entered into a license agreement with Brandeis, or the Brandeis Agreement.”
FILING10-K0001104659-26-036494cik 0001735438
“Additionally, in December 2025, we entered into an agreement with ZipBio, a biotechnology company pioneering AI-driven protein therapeutics, which granted MeiraGTx an exclusive license to several proprietary AI-designed complement inhibitors.”
FILING10-K0001104659-26-036494cik 0001735438
“In October 2023, we announced that under the terms of the Investment Agreement (the "Investment Agreement") we entered into with Sanofi Foreign Participations B.V. ("Sanofi Foreign Participations"), a wholly-owned subsidiary of Sanofi, and solely for the limited purposes set forth therein, Sanofi, Sanofi has a right of first negotiation for use of our riboswitch gene regulation technology for certain Immunology and Inflammation (I&I), including modulation of IL-4 and IL-13, and Central Nervous System (CNS) targets, as well as for GLP-1 and other gut peptides for metabolic disease, and for our Phase 2 xerostomia program.”
FILING10-K0001104659-26-036494cik 0001735438
“Certain of our issued patents and pending patent applications are exclusively licensed to us from UCLB, Brandeis University ("Brandeis") and the National Institute of Dental and Craniofacial Research ("NIDCR").”
FILING10-K0001104659-26-036494cik 0001735438
“Hologen will also contribute a portion of the annual funding to MeiraGTx Manufacturing.”
FILING10-K0001104659-26-036494cik 0001735438
Watchlist prices, news filtered to it, and its next report on your desk.
MGTX (MeiraGTx Holdings plc) has 4 disclosed suppliers and 4 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: LLY +0.28%, in healthcare.